Establishment Labs (ESTA) Competitors $43.97 -2.14 (-4.64%) Closing price 07/8/2025 04:00 PM EasternExtended Trading$43.76 -0.20 (-0.47%) As of 07/8/2025 06:15 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock ESTA vs. NARI, TMDX, BLCO, SLNO, INSP, NVST, PRCT, LIVN, WRBY, and NVCRShould you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry. Establishment Labs vs. Its Competitors Inari Medical TransMedics Group Bausch + Lomb Soleno Therapeutics Inspire Medical Systems Envista PROCEPT BioRobotics LivaNova Warby Parker NovoCure Inari Medical (NASDAQ:NARI) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations. Do insiders & institutionals hold more shares of NARI or ESTA? 91.0% of Inari Medical shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 10.6% of Inari Medical shares are held by insiders. Comparatively, 11.4% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term. Is NARI or ESTA more profitable? Inari Medical has a net margin of -13.68% compared to Establishment Labs' net margin of -52.34%. Inari Medical's return on equity of -10.09% beat Establishment Labs' return on equity.Company Net Margins Return on Equity Return on Assets Inari Medical-13.68% -10.09% -6.60% Establishment Labs -52.34%-196.25%-26.64% Does the media prefer NARI or ESTA? In the previous week, Establishment Labs had 2 more articles in the media than Inari Medical. MarketBeat recorded 2 mentions for Establishment Labs and 0 mentions for Inari Medical. Establishment Labs' average media sentiment score of 0.34 beat Inari Medical's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the news media. Company Overall Sentiment Inari Medical Neutral Establishment Labs Neutral Which has stronger valuation and earnings, NARI or ESTA? Inari Medical has higher revenue and earnings than Establishment Labs. Inari Medical is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInari Medical$493.63M9.48-$1.64M-$1.35-59.24Establishment Labs$166.02M7.66-$84.60M-$3.10-14.18 Do analysts rate NARI or ESTA? Inari Medical currently has a consensus price target of $69.22, indicating a potential downside of 13.44%. Establishment Labs has a consensus price target of $52.40, indicating a potential upside of 19.17%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Inari Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inari Medical 0 Sell rating(s) 12 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.14Establishment Labs 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80 Which has more volatility & risk, NARI or ESTA? Inari Medical has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500. SummaryInari Medical beats Establishment Labs on 9 of the 16 factors compared between the two stocks. Get Establishment Labs News Delivered to You Automatically Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ESTA vs. The Competition Export to ExcelMetricEstablishment LabsMedical Services IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.33B$7.24B$5.47B$8.95BDividend YieldN/A2.83%5.25%4.04%P/E Ratio-14.1827.3326.9620.11Price / Sales7.6634.17430.20119.79Price / CashN/A23.6936.8257.86Price / Book23.146.727.985.56Net Income-$84.60M$230.16M$3.16B$248.40M7 Day Performance-0.88%1.12%2.39%4.67%1 Month Performance14.24%2.31%2.18%6.64%1 Year Performance-0.72%49.95%33.82%21.31% Establishment Labs Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ESTAEstablishment Labs1.2076 of 5 stars$43.97-4.6%$52.40+19.2%-2.2%$1.33B$166.02M-14.181,018NARIInari MedicalN/A$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800TMDXTransMedics Group1.6918 of 5 stars$134.01+1.9%$127.33-5.0%-16.4%$4.45B$441.54M98.54210BLCOBausch + Lomb3.1036 of 5 stars$13.03+5.1%$15.54+19.3%-8.2%$4.39B$4.79B-12.6513,500Analyst ForecastHigh Trading VolumeSLNOSoleno Therapeutics4.7672 of 5 stars$83.78+0.6%$107.10+27.8%+101.0%$4.20BN/A-18.1330INSPInspire Medical Systems4.8288 of 5 stars$129.28-2.4%$211.91+63.9%-1.7%$3.91B$802.80M59.581,246News CoveragePositive NewsNVSTEnvista3.8163 of 5 stars$19.58-0.5%$20.23+3.3%+22.8%$3.33B$2.51B-3.0012,300PRCTPROCEPT BioRobotics2.6677 of 5 stars$57.60+1.2%$90.00+56.3%-9.8%$3.15B$224.50M-33.88430Analyst ForecastLIVNLivaNova3.2051 of 5 stars$45.02-1.6%$59.29+31.7%-9.6%$2.49B$1.25B-11.012,900Positive NewsWRBYWarby Parker1.9588 of 5 stars$21.94+0.2%$22.88+4.3%+45.0%$2.29B$771.32M-182.833,780NVCRNovoCure3.5853 of 5 stars$17.80-1.1%$32.83+84.5%+9.4%$2.01B$605.22M-11.791,488Analyst Forecast Related Companies and Tools Related Companies Inari Medical Alternatives TransMedics Group Alternatives Bausch + Lomb Alternatives Soleno Therapeutics Alternatives Inspire Medical Systems Alternatives Envista Alternatives PROCEPT BioRobotics Alternatives LivaNova Alternatives Warby Parker Alternatives NovoCure Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ESTA) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredElon’s RevengeElon Musk and President Trump's new feud is all over the news... But what no one has reported – yet – is th...Altimetry | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Establishment Labs Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Establishment Labs With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
